NANOSTHERAPEUTICS.COM: Keyword Density Checker

Total words: 2265 | 2-word phrases: 581 | 3-word phrases: 650 | 4-word phrases: 683

PAGE INFO

Title	Try to keep the title under 60 characters (29 characters) HOME - Nanoscope Therapeutics
Description	Try to keep the meta description between 50 - 160 characters (229 characters) Nanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal degenerations as well as dry AMD.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (22 characters) Nanoscope Therapeutics

#	Keyword	Frequency	Density
1	press releasehome page	6	0.92%
2	page nanoscope therapeutics	6	0.92%
3	releasehome page nanoscope	6	0.92%
4	nanoscope press releasehome	5	0.77%
5	patient in our	5	0.77%
6	2024 nanoscope press	4	0.62%
7	for retinitis pigmentosa	4	0.62%
8	a patient in	4	0.62%
9	read more may	4	0.62%
10	nanoscope therapeutics to	4	0.62%
11	clinical trial for	4	0.62%
12	read more april	3	0.46%
13	in our restore	3	0.46%
14	trial for retinitis	3	0.46%
15	to present at	2	0.31%
16	the light of	2	0.31%
17	back the light	2	0.31%
18	present at the	2	0.31%
19	audacious goal initiative	2	0.31%
20	therapeutics to present	2	0.31%
21	nanoscope newsevents nanoscope	2	0.31%
22	of the retina	2	0.31%
23	therapeutics announces presentations	2	0.31%
24	retinal degenerative diseases	2	0.31%
25	in our starlight	2	0.31%
26	our starlight clinical	2	0.31%
27	starlight clinical trial	2	0.31%
28	to experience vision	2	0.31%
29	experience vision loss	2	0.31%
30	vision loss as	2	0.31%

#	Keyword	Frequency	Density
1	releasehome page nanoscope therapeutics	5	0.73%
2	press releasehome page nanoscope	5	0.73%
3	a patient in our	4	0.59%
4	nanoscope press releasehome page	4	0.59%
5	trial for retinitis pigmentosa	3	0.44%
6	2024 nanoscope press releasehome	3	0.44%
7	page nanoscope therapeutics to	3	0.44%
8	clinical trial for retinitis	3	0.44%
9	patient in our restore	3	0.44%
10	nanoscope therapeutics to present	2	0.29%
11	to experience vision loss	2	0.29%
12	read more may 2	2	0.29%
13	bringing back the light	2	0.29%
14	back the light of	2	0.29%
15	patient in our starlight	2	0.29%
16	in our starlight clinical	2	0.29%
17	therapeutics to present at	2	0.29%
18	our starlight clinical trial	2	0.29%
19	meeting read more may	1	0.15%
20	more may 7 2024	1	0.15%
21	in upcoming asgct annual	1	0.15%
22	upcoming asgct annual meeting	1	0.15%
23	and retina world congress	1	0.15%
24	ois and retinal cell	1	0.15%
25	the ois and retinal	1	0.15%
26	retina world congress read	1	0.15%
27	world congress read more	1	0.15%
28	congress read more may	1	0.15%
29	read more may 7	1	0.15%
30	may 7 2024 nanoscope	1	0.15%
31	annual meeting read more	1	0.15%
32	7 2024 nanoscope press	1	0.15%
33	therapeutics announces presentations at	1	0.15%
34	announces presentations at the	1	0.15%
35	arvo annual meeting read	1	0.15%
36	at the ois and	1	0.15%
37	present at the ois	1	0.15%
38	2 2024 nanoscope press	1	0.15%
39	may 2 2024 nanoscope	1	0.15%
40	and retinal cell and	1	0.15%